The size of the Veterinary Healthcare Market in Latin America was worth USD 3.74 billion in 2022. It is further expected to grow and worth USD 5.52 billion by 2027, growing at a CAGR of 8.1% from 2022 to 2027.
Veterinary medicine can be defined as the science associated with diagnosing, treating, and preventing diseases in animals. The scope of Veterinary medicine is broad, covering various animal species, both domestic and wild. The increasing importance of the production of livestock animals is generating growth in the animal healthcare market. An ever-increasing population and a stable economy are expected to increase the demand for protein-rich foods, especially in developing countries.
There is an upsurge in the number of animal ownership as a result of increased love for pets. Rising awareness among individuals regarding animal health and few requirements for animals' drug approval are the primary driving factors for the Veterinary healthcare market. The rising number of foodborne diseases is also aiding the growth of the animal healthcare market.
However, the market has to overcome a few restraints to prosper in the future, including rising regulations on antibiotics and high costs related to animal testing.
This research report on the Latin American Veterinary Healthcare Market has been segmented and sub-segmented into the following categories:
By Animal Type:
By Product:
By Country:
Regionally, the Latin American veterinary healthcare market was growing at a steady rate since 2015 and predicted that the market's future would be stable. In Latin America, the Mexican veterinary healthcare market grew at an aggressive pace and is expected to register a CAGR of 7.94% between 2020 to 2025.
The demand for veterinary products and services is significantly growing in Argentina, driving the growth for the Argentina Veterinary Healthcare market. Various government initiatives regarding the health of the pets and adoption of pets are some other positive signs for the market to grow further.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Pharmaceuticals
5.1.1.1 Vaccines
5.1.1.2 Antibiotics
5.1.1.3 Parasiticides
5.1.1.4 Others
5.1.2 Feed Additives
5.1.2.1 Medical Feed Additives
5.1.2.2 Nutritional Feed Additives
5.1.3 Y-o-Y Growth Analysis, By Product
5.1.4 Market Attractiveness Analysis, By Product
5.1.5 Market Share Analysis, By Product
5.2 Animal Type
5.2.1 Livestock Animals
5.2.1.1 Cattle
5.2.1.2 Swine
5.2.1.3 Sheep
5.2.1.4 Poultry
5.2.1.5 Aquatic
5.2.1.6 Others
5.2.2 Companion Animals
5.2.2.1 Dogs
5.2.2.2 Cats
5.2.3 Y-o-Y Growth Analysis, By Animal Type
5.2.4 Market Attractiveness Analysis, By Animal Type
5.2.5 Market Share Analysis, By Animal Type
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Animal Type
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Animal Type
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Animal Type
6.2 Brazil
6.3 Mexico
6.4 Rest of Latin America
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 MSD Animal Health
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Bayer AG
8.3 Boehringer Ingelheim GmbH
8.4 Ceva Santé Animale
8.5 Eli Lilly and Company
8.6 Cargill, Inc
8.7 Novasep
8.8 Koninklijke DSM N.V
8.9 Nutreco N.V.
8.10 SeQuent Scientific Ltd.
8.11 Virbac S.A.
8.12 Vétoquinol S.A.
8.13 Zoetis Inc.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.